M Vanrumbeke
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Virus-based gene therapy research
Papers in
-
- Acute Myeloid Leukemia Research 4
- Oncology 6
- Cancer-related Molecular Pathways 4
- Co-authors
- Claude PreudhommePierre FenauxEric WattelF BautersPascale LepelleyBruno QuesnelJL LaïI. Quiquandon
- Journals
- British Journal of Haematology (3 papers)Leukemia Research (3 papers)Leukemia (2 papers)Gene Therapy (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
M Vanrumbeke
18 papers receiving 926 citations
Peers
Comparison fields: 5 of 55
- Hematology 438
- Genetics 276
- Oncology 444
- Pathology and Forensic Medicine 187
- Cancer Research 125
Countries citing papers authored by M Vanrumbeke
This map shows the geographic impact of M Vanrumbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Vanrumbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Vanrumbeke more than expected).
Fields of papers citing papers by M Vanrumbeke
This network shows the impact of papers produced by M Vanrumbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Vanrumbeke. The network helps show where M Vanrumbeke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M Vanrumbeke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 46 | |
| 2 | 1998 | 3 | |
| 3 | 1997 | 40 | |
| 4 | 1997 | 60 | |
| 5 | 1997 | 2 | |
| 6 | Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. | 1996 | 47 |
| 7 | 1995 | 67 | |
| 8 | 1995 | 117 | |
| 9 | Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations. | 1995 | 141 |
| 10 | 1994 | 6 | |
| 11 | Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia. | 1994 | 12 |
| 12 | Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia. | 1994 | 21 |
| 13 | 1994 | 1 | |
| 14 | Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. | 1994 | 68 |
| 15 | Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. | 1992 | 122 |
| 16 | 1992 | 93 | |
| 17 | 1992 | 62 | |
| 18 | Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases. | 1992 | 49 |
About M Vanrumbeke
M Vanrumbeke is a scholar working on Hematology, Oncology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 957 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Cancer-related Molecular Pathways (4 papers), Virus-based gene therapy research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Cancer Genomics and Diagnostics (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Hematology (438 citations), Genetics (276 citations), Oncology (444 citations), Pathology and Forensic Medicine (187 citations) and Cancer Research (125 citations). M Vanrumbeke has collaborated with scholars based in France and United States. Frequent co-authors include Claude Preudhomme, Pierre Fenaux, Eric Wattel, F Bauters, Pascale Lepelley, Bruno Quesnel, JL Laï, I. Quiquandon, Marc Zandecki and M Flactif. Their work appears in journals such as British Journal of Haematology, Leukemia Research, Leukemia, Gene Therapy and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.